evenfolioETF Details
Fidelity Investments·Health·FMED · Nasdaq
Fidelity Disruptive Medicine ETF (FMED)
- Price
- $32.41
- —30 Oct 2026
- Assets
- $52.3M
- Total net assets
- Expense ratio
- 0.50%
- Category 1.00%
- Yield
- 0.00%
- Trailing distributions
- 1Y return
- 23.4%-5.4%
- Category 28.8%
- 3Y CAGR
- 17.7%-3.8%
- Category 21.5%
- 5Y CAGR
- —
- Category 4.1%
Loading NAV history…
Fidelity Disruptive Medicine ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +0.1% | +15.8% | +31.2% | +19.8% | +23.4% | +17.7% | — | — | +7.8% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -3.5% | +5.9% | +8.2% | -0.6% | -5.4% | -3.8% | — | — | -3.9% |
Holdings
The 9 largest positions make up 33.0% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 5.79% |
| NTRA | Natera Inc | 4.43% |
| TMO | Thermo Fisher Scientific Inc | 4.13% |
| DHR | Danaher Corp | 3.81% |
| ILMN | Illumina Inc | 3.56% |
| ARGX | argenx SE ADR | 2.93% |
| LFST | LifeStance Health Group Inc Ordinary Shares | 2.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.83% |
| DIM.PA | Sartorius Stedim Biotech SA | 2.67% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 5.6
- P/S
- 6.0
- P/CF
- 29.1
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks98.9%
- Cash14.5%
ETF details
- Issuer
- Fidelity Investments
- Category
- Equity · Health
- Ticker
- FMED
- Exchange
- Nasdaq
- Inception
- 16 Apr 2020 (6.5 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.50% (category 1.00%)
- Holdings turnover
- 49% (category 51%)
- Distribution yield
- 0.00%
- Beta, 3 years
- 0.74
- Total net assets
- $52.3M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- BBC · Virtus Biotech Clinical Trials ETFVirtus · $43.8M · ER 0.65%5Y 0.0%
- MEDI · Harbor Health Care ETFHarbor Capital Advisors Inc · $41.7M · ER 0.80%
- HELX · Franklin Genomic Advancements ETFFranklin Templeton, Inc · $33.4M · ER 0.50%5Y -3.1%
- TMED · T. Rowe Price Health Care ETFT. Rowe Price · $33M · ER 0.44%
- HEAL · Global X HealthTech ETFGlobal X Funds · $31M · ER 0.50%5Y -10.9%
- GDOC · Future Health Care Equity ETFGoldman Sachs · $19.5M · ER 0.75%